NVX-412, a New Oncology Drug Candidate, Induces S-Phase Arrest and DNA Damage in Cancer Cells in a P53-Independent Manner
PLoS ONE - United States
doi 10.1371/journal.pone.0045015
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 13, 2012
Authors
Publisher
Public Library of Science (PLoS)